Camber Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Camber Capital Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-500,000	Closed	-$12.6M	–	52
2022 Q3	$12.6M	Sell	500,000 -1,000,000	-67%	-$27.7M	0.42%	43
2022 Q2	$45.6M	Hold	1,500,000	–	–	1.98%	17
2022 Q1	$49.1M	Buy	+1,500,000	New	+$44.5M	1.78%	20
2021 Q4	–	Sell	-685,000	Closed	-$68.9M	–	46
2021 Q3	$68.9M	Buy	685,000 +220,000	+47%	+$25.8M	2.56%	24
2021 Q2	$65.8M	Buy	465,000 +65,000	+16%	+$7.34M	2.59%	22
2021 Q1	$39.9M	Buy	+400,000	New	+$46.7M	1.58%	25

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return